nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Clobetasol propionate—psoriasis	0.0944	0.225	CbGbCtD
Ropinirole—CYP1A2—Methoxsalen—psoriasis	0.0496	0.118	CbGbCtD
Ropinirole—CYP2D6—Hydroxyurea—psoriasis	0.0447	0.106	CbGbCtD
Ropinirole—CYP3A4—Calcitriol—psoriasis	0.0334	0.0796	CbGbCtD
Ropinirole—CYP2D6—Cholecalciferol—psoriasis	0.0271	0.0645	CbGbCtD
Ropinirole—CYP3A4—Methoxsalen—psoriasis	0.026	0.0619	CbGbCtD
Ropinirole—CYP2D6—Cyclosporine—psoriasis	0.0178	0.0424	CbGbCtD
Ropinirole—CYP3A4—Cholecalciferol—psoriasis	0.0172	0.041	CbGbCtD
Ropinirole—CYP3A4—Mycophenolate mofetil—psoriasis	0.0149	0.0355	CbGbCtD
Ropinirole—CYP3A4—Triamcinolone—psoriasis	0.0149	0.0355	CbGbCtD
Ropinirole—CYP3A4—Betamethasone—psoriasis	0.0128	0.0305	CbGbCtD
Ropinirole—CYP3A4—Prednisolone—psoriasis	0.0126	0.0301	CbGbCtD
Ropinirole—CYP3A4—Hydrocortisone—psoriasis	0.012	0.0285	CbGbCtD
Ropinirole—CYP3A4—Prednisone—psoriasis	0.0119	0.0284	CbGbCtD
Ropinirole—CYP2D6—Dexamethasone—psoriasis	0.0117	0.0279	CbGbCtD
Ropinirole—CYP3A4—Cyclosporine—psoriasis	0.0113	0.0269	CbGbCtD
Ropinirole—CYP3A4—Dexamethasone—psoriasis	0.00745	0.0177	CbGbCtD
Ropinirole—Vomiting—Mycophenolic acid—psoriasis	6.2e-05	0.000112	CcSEcCtD
Ropinirole—Discomfort—Dexamethasone—psoriasis	6.17e-05	0.000112	CcSEcCtD
Ropinirole—Discomfort—Betamethasone—psoriasis	6.17e-05	0.000112	CcSEcCtD
Ropinirole—Dyspepsia—Hydrocortisone—psoriasis	6.17e-05	0.000112	CcSEcCtD
Ropinirole—Haemoglobin—Methotrexate—psoriasis	6.16e-05	0.000112	CcSEcCtD
Ropinirole—Rash—Mycophenolic acid—psoriasis	6.14e-05	0.000112	CcSEcCtD
Ropinirole—Dermatitis—Mycophenolic acid—psoriasis	6.14e-05	0.000111	CcSEcCtD
Ropinirole—Pain—Prednisolone—psoriasis	6.13e-05	0.000111	CcSEcCtD
Ropinirole—Haemorrhage—Methotrexate—psoriasis	6.13e-05	0.000111	CcSEcCtD
Ropinirole—Urticaria—Mycophenolate mofetil—psoriasis	6.11e-05	0.000111	CcSEcCtD
Ropinirole—Headache—Mycophenolic acid—psoriasis	6.1e-05	0.000111	CcSEcCtD
Ropinirole—Decreased appetite—Hydrocortisone—psoriasis	6.09e-05	0.000111	CcSEcCtD
Ropinirole—Pharyngitis—Methotrexate—psoriasis	6.09e-05	0.00011	CcSEcCtD
Ropinirole—Abdominal pain—Mycophenolate mofetil—psoriasis	6.08e-05	0.00011	CcSEcCtD
Ropinirole—Body temperature increased—Mycophenolate mofetil—psoriasis	6.08e-05	0.00011	CcSEcCtD
Ropinirole—Urinary tract disorder—Methotrexate—psoriasis	6.06e-05	0.00011	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.05e-05	0.00011	CcSEcCtD
Ropinirole—Fatigue—Hydrocortisone—psoriasis	6.04e-05	0.00011	CcSEcCtD
Ropinirole—Vision blurred—Prednisone—psoriasis	6.02e-05	0.000109	CcSEcCtD
Ropinirole—Urethral disorder—Methotrexate—psoriasis	6.01e-05	0.000109	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.01e-05	0.000109	CcSEcCtD
Ropinirole—Pain—Hydrocortisone—psoriasis	5.99e-05	0.000109	CcSEcCtD
Ropinirole—Oedema—Betamethasone—psoriasis	5.99e-05	0.000109	CcSEcCtD
Ropinirole—Oedema—Dexamethasone—psoriasis	5.99e-05	0.000109	CcSEcCtD
Ropinirole—Insomnia—Triamcinolone—psoriasis	5.97e-05	0.000108	CcSEcCtD
Ropinirole—Infection—Betamethasone—psoriasis	5.95e-05	0.000108	CcSEcCtD
Ropinirole—Infection—Dexamethasone—psoriasis	5.95e-05	0.000108	CcSEcCtD
Ropinirole—Ill-defined disorder—Prednisone—psoriasis	5.93e-05	0.000108	CcSEcCtD
Ropinirole—Paraesthesia—Triamcinolone—psoriasis	5.92e-05	0.000108	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisolone—psoriasis	5.91e-05	0.000107	CcSEcCtD
Ropinirole—Visual impairment—Methotrexate—psoriasis	5.91e-05	0.000107	CcSEcCtD
Ropinirole—Anaemia—Prednisone—psoriasis	5.9e-05	0.000107	CcSEcCtD
Ropinirole—Shock—Dexamethasone—psoriasis	5.89e-05	0.000107	CcSEcCtD
Ropinirole—Shock—Betamethasone—psoriasis	5.89e-05	0.000107	CcSEcCtD
Ropinirole—Dyspnoea—Triamcinolone—psoriasis	5.88e-05	0.000107	CcSEcCtD
Ropinirole—Nervous system disorder—Betamethasone—psoriasis	5.87e-05	0.000107	CcSEcCtD
Ropinirole—Nervous system disorder—Dexamethasone—psoriasis	5.87e-05	0.000107	CcSEcCtD
Ropinirole—Agitation—Prednisone—psoriasis	5.87e-05	0.000107	CcSEcCtD
Ropinirole—Thrombocytopenia—Betamethasone—psoriasis	5.86e-05	0.000106	CcSEcCtD
Ropinirole—Thrombocytopenia—Dexamethasone—psoriasis	5.86e-05	0.000106	CcSEcCtD
Ropinirole—Tachycardia—Dexamethasone—psoriasis	5.84e-05	0.000106	CcSEcCtD
Ropinirole—Tachycardia—Betamethasone—psoriasis	5.84e-05	0.000106	CcSEcCtD
Ropinirole—Angioedema—Prednisone—psoriasis	5.84e-05	0.000106	CcSEcCtD
Ropinirole—Hypersensitivity—Cyclosporine—psoriasis	5.81e-05	0.000105	CcSEcCtD
Ropinirole—Dyspepsia—Triamcinolone—psoriasis	5.81e-05	0.000105	CcSEcCtD
Ropinirole—Nausea—Mycophenolic acid—psoriasis	5.79e-05	0.000105	CcSEcCtD
Ropinirole—Hyperhidrosis—Betamethasone—psoriasis	5.79e-05	0.000105	CcSEcCtD
Ropinirole—Hyperhidrosis—Dexamethasone—psoriasis	5.79e-05	0.000105	CcSEcCtD
Ropinirole—Feeling abnormal—Hydrocortisone—psoriasis	5.77e-05	0.000105	CcSEcCtD
Ropinirole—Malaise—Prednisone—psoriasis	5.76e-05	0.000105	CcSEcCtD
Ropinirole—Vertigo—Prednisone—psoriasis	5.74e-05	0.000104	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—psoriasis	5.73e-05	0.000104	CcSEcCtD
Ropinirole—Gastrointestinal pain—Hydrocortisone—psoriasis	5.73e-05	0.000104	CcSEcCtD
Ropinirole—Syncope—Prednisone—psoriasis	5.73e-05	0.000104	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—psoriasis	5.72e-05	0.000104	CcSEcCtD
Ropinirole—Anorexia—Dexamethasone—psoriasis	5.71e-05	0.000104	CcSEcCtD
Ropinirole—Anorexia—Betamethasone—psoriasis	5.71e-05	0.000104	CcSEcCtD
Ropinirole—Urticaria—Prednisolone—psoriasis	5.7e-05	0.000103	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—psoriasis	5.69e-05	0.000103	CcSEcCtD
Ropinirole—Fatigue—Triamcinolone—psoriasis	5.69e-05	0.000103	CcSEcCtD
Ropinirole—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.67e-05	0.000103	CcSEcCtD
Ropinirole—Asthenia—Cyclosporine—psoriasis	5.66e-05	0.000103	CcSEcCtD
Ropinirole—Pain—Triamcinolone—psoriasis	5.64e-05	0.000102	CcSEcCtD
Ropinirole—Loss of consciousness—Prednisone—psoriasis	5.61e-05	0.000102	CcSEcCtD
Ropinirole—Hypotension—Dexamethasone—psoriasis	5.59e-05	0.000102	CcSEcCtD
Ropinirole—Hypotension—Betamethasone—psoriasis	5.59e-05	0.000102	CcSEcCtD
Ropinirole—Pruritus—Cyclosporine—psoriasis	5.58e-05	0.000101	CcSEcCtD
Ropinirole—Urticaria—Hydrocortisone—psoriasis	5.57e-05	0.000101	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—psoriasis	5.56e-05	0.000101	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—psoriasis	5.54e-05	0.000101	CcSEcCtD
Ropinirole—Abdominal pain—Hydrocortisone—psoriasis	5.54e-05	0.000101	CcSEcCtD
Ropinirole—Body temperature increased—Hydrocortisone—psoriasis	5.54e-05	0.000101	CcSEcCtD
Ropinirole—Convulsion—Prednisone—psoriasis	5.53e-05	0.0001	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—psoriasis	5.53e-05	0.0001	CcSEcCtD
Ropinirole—Asthenia—Mycophenolate mofetil—psoriasis	5.52e-05	0.0001	CcSEcCtD
Ropinirole—Hypertension—Prednisone—psoriasis	5.51e-05	0.0001	CcSEcCtD
Ropinirole—Chills—Methotrexate—psoriasis	5.5e-05	9.99e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Betamethasone—psoriasis	5.45e-05	9.9e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.45e-05	9.9e-05	CcSEcCtD
Ropinirole—Pruritus—Mycophenolate mofetil—psoriasis	5.44e-05	9.88e-05	CcSEcCtD
Ropinirole—Myalgia—Prednisone—psoriasis	5.44e-05	9.87e-05	CcSEcCtD
Ropinirole—Arthralgia—Prednisone—psoriasis	5.44e-05	9.87e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Triamcinolone—psoriasis	5.44e-05	9.87e-05	CcSEcCtD
Ropinirole—Anxiety—Prednisone—psoriasis	5.42e-05	9.84e-05	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—psoriasis	5.42e-05	9.84e-05	CcSEcCtD
Ropinirole—Insomnia—Dexamethasone—psoriasis	5.41e-05	9.83e-05	CcSEcCtD
Ropinirole—Insomnia—Betamethasone—psoriasis	5.41e-05	9.83e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.4e-05	9.8e-05	CcSEcCtD
Ropinirole—Diarrhoea—Cyclosporine—psoriasis	5.39e-05	9.79e-05	CcSEcCtD
Ropinirole—Paraesthesia—Dexamethasone—psoriasis	5.37e-05	9.76e-05	CcSEcCtD
Ropinirole—Paraesthesia—Betamethasone—psoriasis	5.37e-05	9.76e-05	CcSEcCtD
Ropinirole—Discomfort—Prednisone—psoriasis	5.37e-05	9.75e-05	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—psoriasis	5.37e-05	9.75e-05	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—psoriasis	5.34e-05	9.69e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisolone—psoriasis	5.28e-05	9.59e-05	CcSEcCtD
Ropinirole—Dyspepsia—Dexamethasone—psoriasis	5.27e-05	9.56e-05	CcSEcCtD
Ropinirole—Dyspepsia—Betamethasone—psoriasis	5.27e-05	9.56e-05	CcSEcCtD
Ropinirole—Diarrhoea—Mycophenolate mofetil—psoriasis	5.26e-05	9.55e-05	CcSEcCtD
Ropinirole—Urticaria—Triamcinolone—psoriasis	5.24e-05	9.51e-05	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—psoriasis	5.23e-05	9.49e-05	CcSEcCtD
Ropinirole—Body temperature increased—Triamcinolone—psoriasis	5.21e-05	9.47e-05	CcSEcCtD
Ropinirole—Dizziness—Cyclosporine—psoriasis	5.21e-05	9.46e-05	CcSEcCtD
Ropinirole—Oedema—Prednisone—psoriasis	5.21e-05	9.46e-05	CcSEcCtD
Ropinirole—Decreased appetite—Betamethasone—psoriasis	5.2e-05	9.45e-05	CcSEcCtD
Ropinirole—Decreased appetite—Dexamethasone—psoriasis	5.2e-05	9.45e-05	CcSEcCtD
Ropinirole—Infection—Prednisone—psoriasis	5.18e-05	9.4e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Dexamethasone—psoriasis	5.17e-05	9.38e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Betamethasone—psoriasis	5.17e-05	9.38e-05	CcSEcCtD
Ropinirole—Back pain—Methotrexate—psoriasis	5.16e-05	9.37e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Hydrocortisone—psoriasis	5.16e-05	9.37e-05	CcSEcCtD
Ropinirole—Fatigue—Dexamethasone—psoriasis	5.16e-05	9.37e-05	CcSEcCtD
Ropinirole—Fatigue—Betamethasone—psoriasis	5.16e-05	9.37e-05	CcSEcCtD
Ropinirole—Shock—Prednisone—psoriasis	5.13e-05	9.31e-05	CcSEcCtD
Ropinirole—Pain—Betamethasone—psoriasis	5.12e-05	9.29e-05	CcSEcCtD
Ropinirole—Pain—Dexamethasone—psoriasis	5.12e-05	9.29e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Prednisone—psoriasis	5.11e-05	9.28e-05	CcSEcCtD
Ropinirole—Tachycardia—Prednisone—psoriasis	5.09e-05	9.23e-05	CcSEcCtD
Ropinirole—Dizziness—Mycophenolate mofetil—psoriasis	5.09e-05	9.23e-05	CcSEcCtD
Ropinirole—Skin disorder—Prednisone—psoriasis	5.06e-05	9.19e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisone—psoriasis	5.04e-05	9.15e-05	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—psoriasis	5.03e-05	9.13e-05	CcSEcCtD
Ropinirole—Asthenia—Hydrocortisone—psoriasis	5.03e-05	9.12e-05	CcSEcCtD
Ropinirole—Vomiting—Cyclosporine—psoriasis	5.01e-05	9.1e-05	CcSEcCtD
Ropinirole—Rash—Cyclosporine—psoriasis	4.97e-05	9.02e-05	CcSEcCtD
Ropinirole—Anorexia—Prednisone—psoriasis	4.97e-05	9.02e-05	CcSEcCtD
Ropinirole—Dermatitis—Cyclosporine—psoriasis	4.97e-05	9.01e-05	CcSEcCtD
Ropinirole—Pruritus—Hydrocortisone—psoriasis	4.96e-05	9e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—psoriasis	4.95e-05	8.99e-05	CcSEcCtD
Ropinirole—Headache—Cyclosporine—psoriasis	4.94e-05	8.96e-05	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—psoriasis	4.93e-05	8.96e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Dexamethasone—psoriasis	4.93e-05	8.95e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Betamethasone—psoriasis	4.93e-05	8.95e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Betamethasone—psoriasis	4.89e-05	8.88e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Dexamethasone—psoriasis	4.89e-05	8.88e-05	CcSEcCtD
Ropinirole—Vomiting—Mycophenolate mofetil—psoriasis	4.89e-05	8.88e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Triamcinolone—psoriasis	4.86e-05	8.82e-05	CcSEcCtD
Ropinirole—Rash—Mycophenolate mofetil—psoriasis	4.85e-05	8.8e-05	CcSEcCtD
Ropinirole—Dermatitis—Mycophenolate mofetil—psoriasis	4.84e-05	8.79e-05	CcSEcCtD
Ropinirole—Headache—Mycophenolate mofetil—psoriasis	4.82e-05	8.74e-05	CcSEcCtD
Ropinirole—Malaise—Methotrexate—psoriasis	4.81e-05	8.74e-05	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—psoriasis	4.8e-05	8.71e-05	CcSEcCtD
Ropinirole—Diarrhoea—Hydrocortisone—psoriasis	4.79e-05	8.7e-05	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—psoriasis	4.78e-05	8.67e-05	CcSEcCtD
Ropinirole—Urticaria—Betamethasone—psoriasis	4.75e-05	8.63e-05	CcSEcCtD
Ropinirole—Urticaria—Dexamethasone—psoriasis	4.75e-05	8.63e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Prednisone—psoriasis	4.75e-05	8.62e-05	CcSEcCtD
Ropinirole—Dizziness—Prednisolone—psoriasis	4.74e-05	8.61e-05	CcSEcCtD
Ropinirole—Asthenia—Triamcinolone—psoriasis	4.73e-05	8.59e-05	CcSEcCtD
Ropinirole—Body temperature increased—Betamethasone—psoriasis	4.73e-05	8.59e-05	CcSEcCtD
Ropinirole—Abdominal pain—Dexamethasone—psoriasis	4.73e-05	8.59e-05	CcSEcCtD
Ropinirole—Abdominal pain—Betamethasone—psoriasis	4.73e-05	8.59e-05	CcSEcCtD
Ropinirole—Body temperature increased—Dexamethasone—psoriasis	4.73e-05	8.59e-05	CcSEcCtD
Ropinirole—Insomnia—Prednisone—psoriasis	4.71e-05	8.56e-05	CcSEcCtD
Ropinirole—Nausea—Cyclosporine—psoriasis	4.68e-05	8.5e-05	CcSEcCtD
Ropinirole—Paraesthesia—Prednisone—psoriasis	4.68e-05	8.5e-05	CcSEcCtD
Ropinirole—Pruritus—Triamcinolone—psoriasis	4.67e-05	8.47e-05	CcSEcCtD
Ropinirole—Cough—Methotrexate—psoriasis	4.66e-05	8.46e-05	CcSEcCtD
Ropinirole—Dizziness—Hydrocortisone—psoriasis	4.63e-05	8.41e-05	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—psoriasis	4.62e-05	8.4e-05	CcSEcCtD
Ropinirole—Dyspepsia—Prednisone—psoriasis	4.59e-05	8.33e-05	CcSEcCtD
Ropinirole—Nausea—Mycophenolate mofetil—psoriasis	4.57e-05	8.29e-05	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—psoriasis	4.54e-05	8.25e-05	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—psoriasis	4.54e-05	8.25e-05	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—psoriasis	4.54e-05	8.25e-05	CcSEcCtD
Ropinirole—Decreased appetite—Prednisone—psoriasis	4.53e-05	8.23e-05	CcSEcCtD
Ropinirole—Rash—Prednisolone—psoriasis	4.52e-05	8.21e-05	CcSEcCtD
Ropinirole—Dermatitis—Prednisolone—psoriasis	4.52e-05	8.2e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.51e-05	8.19e-05	CcSEcCtD
Ropinirole—Fatigue—Prednisone—psoriasis	4.49e-05	8.16e-05	CcSEcCtD
Ropinirole—Headache—Prednisolone—psoriasis	4.49e-05	8.16e-05	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—psoriasis	4.49e-05	8.15e-05	CcSEcCtD
Ropinirole—Constipation—Prednisone—psoriasis	4.46e-05	8.09e-05	CcSEcCtD
Ropinirole—Vomiting—Hydrocortisone—psoriasis	4.45e-05	8.09e-05	CcSEcCtD
Ropinirole—Rash—Hydrocortisone—psoriasis	4.42e-05	8.02e-05	CcSEcCtD
Ropinirole—Dermatitis—Hydrocortisone—psoriasis	4.41e-05	8.01e-05	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—psoriasis	4.39e-05	7.97e-05	CcSEcCtD
Ropinirole—Headache—Hydrocortisone—psoriasis	4.39e-05	7.97e-05	CcSEcCtD
Ropinirole—Dizziness—Triamcinolone—psoriasis	4.36e-05	7.92e-05	CcSEcCtD
Ropinirole—Infection—Methotrexate—psoriasis	4.33e-05	7.86e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisone—psoriasis	4.3e-05	7.8e-05	CcSEcCtD
Ropinirole—Asthenia—Dexamethasone—psoriasis	4.29e-05	7.8e-05	CcSEcCtD
Ropinirole—Asthenia—Betamethasone—psoriasis	4.29e-05	7.8e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—psoriasis	4.27e-05	7.76e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—psoriasis	4.27e-05	7.74e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Prednisone—psoriasis	4.26e-05	7.74e-05	CcSEcCtD
Ropinirole—Nausea—Prednisolone—psoriasis	4.26e-05	7.73e-05	CcSEcCtD
Ropinirole—Pruritus—Betamethasone—psoriasis	4.23e-05	7.69e-05	CcSEcCtD
Ropinirole—Pruritus—Dexamethasone—psoriasis	4.23e-05	7.69e-05	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—psoriasis	4.23e-05	7.68e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—psoriasis	4.21e-05	7.64e-05	CcSEcCtD
Ropinirole—Vomiting—Triamcinolone—psoriasis	4.19e-05	7.61e-05	CcSEcCtD
Ropinirole—Nausea—Hydrocortisone—psoriasis	4.16e-05	7.55e-05	CcSEcCtD
Ropinirole—Rash—Triamcinolone—psoriasis	4.16e-05	7.55e-05	CcSEcCtD
Ropinirole—Dermatitis—Triamcinolone—psoriasis	4.16e-05	7.54e-05	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—psoriasis	4.15e-05	7.54e-05	CcSEcCtD
Ropinirole—Urticaria—Prednisone—psoriasis	4.14e-05	7.52e-05	CcSEcCtD
Ropinirole—Headache—Triamcinolone—psoriasis	4.13e-05	7.5e-05	CcSEcCtD
Ropinirole—Abdominal pain—Prednisone—psoriasis	4.12e-05	7.48e-05	CcSEcCtD
Ropinirole—Body temperature increased—Prednisone—psoriasis	4.12e-05	7.48e-05	CcSEcCtD
Ropinirole—Diarrhoea—Dexamethasone—psoriasis	4.1e-05	7.43e-05	CcSEcCtD
Ropinirole—Diarrhoea—Betamethasone—psoriasis	4.1e-05	7.43e-05	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—psoriasis	4.07e-05	7.39e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—psoriasis	3.97e-05	7.2e-05	CcSEcCtD
Ropinirole—Dizziness—Betamethasone—psoriasis	3.96e-05	7.18e-05	CcSEcCtD
Ropinirole—Dizziness—Dexamethasone—psoriasis	3.96e-05	7.18e-05	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—psoriasis	3.94e-05	7.15e-05	CcSEcCtD
Ropinirole—Nausea—Triamcinolone—psoriasis	3.92e-05	7.11e-05	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—psoriasis	3.91e-05	7.1e-05	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—psoriasis	3.88e-05	7.05e-05	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—psoriasis	3.87e-05	7.03e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisone—psoriasis	3.84e-05	6.97e-05	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—psoriasis	3.83e-05	6.96e-05	CcSEcCtD
Ropinirole—Vomiting—Dexamethasone—psoriasis	3.81e-05	6.91e-05	CcSEcCtD
Ropinirole—Vomiting—Betamethasone—psoriasis	3.81e-05	6.91e-05	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—psoriasis	3.79e-05	6.87e-05	CcSEcCtD
Ropinirole—Rash—Dexamethasone—psoriasis	3.77e-05	6.85e-05	CcSEcCtD
Ropinirole—Rash—Betamethasone—psoriasis	3.77e-05	6.85e-05	CcSEcCtD
Ropinirole—Dermatitis—Dexamethasone—psoriasis	3.77e-05	6.84e-05	CcSEcCtD
Ropinirole—Dermatitis—Betamethasone—psoriasis	3.77e-05	6.84e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—psoriasis	3.76e-05	6.83e-05	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—psoriasis	3.76e-05	6.82e-05	CcSEcCtD
Ropinirole—Headache—Betamethasone—psoriasis	3.75e-05	6.81e-05	CcSEcCtD
Ropinirole—Headache—Dexamethasone—psoriasis	3.75e-05	6.81e-05	CcSEcCtD
Ropinirole—Asthenia—Prednisone—psoriasis	3.74e-05	6.79e-05	CcSEcCtD
Ropinirole—Pain—Methotrexate—psoriasis	3.73e-05	6.76e-05	CcSEcCtD
Ropinirole—Pruritus—Prednisone—psoriasis	3.69e-05	6.69e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—psoriasis	3.59e-05	6.52e-05	CcSEcCtD
Ropinirole—Diarrhoea—Prednisone—psoriasis	3.57e-05	6.47e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—psoriasis	3.56e-05	6.47e-05	CcSEcCtD
Ropinirole—Nausea—Dexamethasone—psoriasis	3.56e-05	6.45e-05	CcSEcCtD
Ropinirole—Nausea—Betamethasone—psoriasis	3.56e-05	6.45e-05	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—psoriasis	3.46e-05	6.28e-05	CcSEcCtD
Ropinirole—Dizziness—Prednisone—psoriasis	3.45e-05	6.26e-05	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—psoriasis	3.44e-05	6.25e-05	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—psoriasis	3.44e-05	6.25e-05	CcSEcCtD
Ropinirole—Vomiting—Prednisone—psoriasis	3.31e-05	6.02e-05	CcSEcCtD
Ropinirole—Rash—Prednisone—psoriasis	3.29e-05	5.97e-05	CcSEcCtD
Ropinirole—Dermatitis—Prednisone—psoriasis	3.28e-05	5.96e-05	CcSEcCtD
Ropinirole—Headache—Prednisone—psoriasis	3.27e-05	5.93e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—psoriasis	3.21e-05	5.83e-05	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—psoriasis	3.13e-05	5.67e-05	CcSEcCtD
Ropinirole—Nausea—Prednisone—psoriasis	3.1e-05	5.62e-05	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—psoriasis	3.08e-05	5.59e-05	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—psoriasis	2.98e-05	5.41e-05	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—psoriasis	2.88e-05	5.23e-05	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—psoriasis	2.77e-05	5.03e-05	CcSEcCtD
Ropinirole—Rash—Methotrexate—psoriasis	2.75e-05	4.99e-05	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—psoriasis	2.74e-05	4.98e-05	CcSEcCtD
Ropinirole—Headache—Methotrexate—psoriasis	2.73e-05	4.95e-05	CcSEcCtD
Ropinirole—Nausea—Methotrexate—psoriasis	2.59e-05	4.7e-05	CcSEcCtD
Ropinirole—HTR2A—GPCR ligand binding—CXCL8—psoriasis	1.52e-05	0.000519	CbGpPWpGaD
Ropinirole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.52e-05	0.000517	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SOCS1—psoriasis	1.46e-05	0.000498	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SOCS1—psoriasis	1.43e-05	0.000488	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SOCS1—psoriasis	1.41e-05	0.00048	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—APOE—psoriasis	1.41e-05	0.00048	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—LEP—psoriasis	1.41e-05	0.00048	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—TYK2—psoriasis	1.39e-05	0.000475	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	1.39e-05	0.000472	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2S1—psoriasis	1.38e-05	0.00047	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—TYK2—psoriasis	1.36e-05	0.000465	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SOCS1—psoriasis	1.34e-05	0.000458	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—TYK2—psoriasis	1.34e-05	0.000458	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—CXCL8—psoriasis	1.34e-05	0.000455	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—VEGFA—psoriasis	1.33e-05	0.000452	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—NFKBIA—psoriasis	1.31e-05	0.000447	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—CXCL8—psoriasis	1.31e-05	0.000446	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—CXCL8—psoriasis	1.29e-05	0.000439	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—TYK2—psoriasis	1.28e-05	0.000437	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.000432	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SOCS1—psoriasis	1.25e-05	0.000426	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—VEGFA—psoriasis	1.24e-05	0.000422	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	1.23e-05	0.000419	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—CXCL8—psoriasis	1.21e-05	0.000413	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—TYK2—psoriasis	1.21e-05	0.000412	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CAT—psoriasis	1.2e-05	0.000408	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—TYK2—psoriasis	1.19e-05	0.000406	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000405	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—CXCL8—psoriasis	1.17e-05	0.000398	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—CXCL8—psoriasis	1.16e-05	0.000395	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—CXCL8—psoriasis	1.14e-05	0.00039	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SOCS1—psoriasis	1.13e-05	0.000385	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—CXCL8—psoriasis	1.12e-05	0.00038	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.09e-05	0.000371	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.08e-05	0.00037	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—LEP—psoriasis	1.08e-05	0.000368	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—APOE—psoriasis	1.08e-05	0.000368	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—TYK2—psoriasis	1.08e-05	0.000367	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TYK2—psoriasis	1.07e-05	0.000366	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—APOE—psoriasis	1.06e-05	0.00036	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—LEP—psoriasis	1.06e-05	0.00036	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SOCS1—psoriasis	1.05e-05	0.000359	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000359	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000354	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—APOE—psoriasis	1.04e-05	0.000354	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—LEP—psoriasis	1.04e-05	0.000354	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.04e-05	0.000354	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.03e-05	0.000352	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000352	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CARM1—psoriasis	1.03e-05	0.000351	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—VEGFA—psoriasis	1.01e-05	0.000343	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.01e-05	0.000343	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1e-05	0.000342	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—TP53—psoriasis	1e-05	0.000342	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	9.96e-06	0.00034	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—APOE—psoriasis	9.92e-06	0.000338	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—LEP—psoriasis	9.92e-06	0.000338	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	9.91e-06	0.000338	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NFKBIA—psoriasis	9.84e-06	0.000335	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CAT—psoriasis	9.73e-06	0.000332	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NFKBIA—psoriasis	9.68e-06	0.00033	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	9.64e-06	0.000329	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SOCS1—psoriasis	9.57e-06	0.000326	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SOCS1—psoriasis	9.41e-06	0.000321	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	9.37e-06	0.000319	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.37e-06	0.000319	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—TP53—psoriasis	9.36e-06	0.000319	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CXCL8—psoriasis	9.35e-06	0.000319	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—LEP—psoriasis	9.35e-06	0.000319	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—APOE—psoriasis	9.35e-06	0.000319	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—APOE—psoriasis	9.31e-06	0.000317	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NFKBIA—psoriasis	9.24e-06	0.000315	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—LEP—psoriasis	9.23e-06	0.000315	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—APOE—psoriasis	9.23e-06	0.000315	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—TYK2—psoriasis	9.12e-06	0.000311	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—CXCL8—psoriasis	9.05e-06	0.000308	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—CXCL8—psoriasis	9e-06	0.000307	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—TYK2—psoriasis	8.98e-06	0.000306	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL6—psoriasis	8.89e-06	0.000303	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	8.75e-06	0.000298	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—CXCL8—psoriasis	8.75e-06	0.000298	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CARM1—psoriasis	8.73e-06	0.000298	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NFKBIA—psoriasis	8.71e-06	0.000297	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—JUN—psoriasis	8.7e-06	0.000296	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	8.61e-06	0.000293	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NFKBIA—psoriasis	8.6e-06	0.000293	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SOCS1—psoriasis	8.56e-06	0.000292	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—NFKB1—psoriasis	8.37e-06	0.000285	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—LEP—psoriasis	8.33e-06	0.000284	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—APOE—psoriasis	8.33e-06	0.000284	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TYK2—psoriasis	8.23e-06	0.000281	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—TYK2—psoriasis	8.17e-06	0.000278	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.16e-06	0.000278	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PPARG—psoriasis	8.11e-06	0.000276	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TYK2—psoriasis	8.06e-06	0.000275	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—APOE—psoriasis	8.04e-06	0.000274	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—LEP—psoriasis	8.04e-06	0.000274	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—LEP—psoriasis	8e-06	0.000273	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—APOE—psoriasis	8e-06	0.000273	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—CXCL8—psoriasis	7.94e-06	0.000271	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TYK2—psoriasis	7.93e-06	0.00027	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	7.83e-06	0.000267	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—CXCL8—psoriasis	7.82e-06	0.000266	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—APOE—psoriasis	7.78e-06	0.000265	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—LEP—psoriasis	7.78e-06	0.000265	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	7.76e-06	0.000265	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TP53—psoriasis	7.6e-06	0.000259	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—VEGFA—psoriasis	7.6e-06	0.000259	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TYK2—psoriasis	7.57e-06	0.000258	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—APOE—psoriasis	7.56e-06	0.000258	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—STAT3—psoriasis	7.52e-06	0.000256	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NFKBIA—psoriasis	7.49e-06	0.000255	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NFKBIA—psoriasis	7.45e-06	0.000254	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	7.25e-06	0.000247	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CXCL8—psoriasis	7.16e-06	0.000244	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TYK2—psoriasis	7.14e-06	0.000243	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	7.11e-06	0.000242	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—LEP—psoriasis	7.06e-06	0.000241	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—APOE—psoriasis	7.06e-06	0.000241	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TYK2—psoriasis	7.04e-06	0.00024	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CXCL8—psoriasis	7.01e-06	0.000239	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—APOE—psoriasis	6.95e-06	0.000237	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—LEP—psoriasis	6.95e-06	0.000237	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CXCL8—psoriasis	6.9e-06	0.000235	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL6—psoriasis	6.81e-06	0.000232	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CARM1—psoriasis	6.74e-06	0.00023	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL6—psoriasis	6.67e-06	0.000227	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—JUN—psoriasis	6.66e-06	0.000227	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CXCL8—psoriasis	6.59e-06	0.000225	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PPARG—psoriasis	6.58e-06	0.000224	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NFKBIA—psoriasis	6.58e-06	0.000224	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL6—psoriasis	6.56e-06	0.000224	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—JUN—psoriasis	6.52e-06	0.000222	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NFKBIA—psoriasis	6.47e-06	0.000221	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—JUN—psoriasis	6.42e-06	0.000219	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NFKB1—psoriasis	6.41e-06	0.000219	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TYK2—psoriasis	6.36e-06	0.000217	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAT—psoriasis	6.34e-06	0.000216	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APOE—psoriasis	6.32e-06	0.000215	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—LEP—psoriasis	6.32e-06	0.000215	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NFKB1—psoriasis	6.28e-06	0.000214	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—psoriasis	6.27e-06	0.000214	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL8—psoriasis	6.21e-06	0.000212	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NFKB1—psoriasis	6.18e-06	0.000211	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TYK2—psoriasis	6.14e-06	0.000209	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL8—psoriasis	6.13e-06	0.000209	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—JUN—psoriasis	6.13e-06	0.000209	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TYK2—psoriasis	6.11e-06	0.000208	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TYK2—psoriasis	5.94e-06	0.000202	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—psoriasis	5.91e-06	0.000201	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NFKB1—psoriasis	5.9e-06	0.000201	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	5.89e-06	0.000201	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—psoriasis	5.83e-06	0.000199	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—psoriasis	5.82e-06	0.000198	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—JUN—psoriasis	5.78e-06	0.000197	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—STAT3—psoriasis	5.76e-06	0.000196	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—psoriasis	5.74e-06	0.000196	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—JUN—psoriasis	5.7e-06	0.000194	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—psoriasis	5.7e-06	0.000194	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—STAT3—psoriasis	5.64e-06	0.000192	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—psoriasis	5.61e-06	0.000191	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NFKB1—psoriasis	5.56e-06	0.00019	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—STAT3—psoriasis	5.55e-06	0.000189	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL8—psoriasis	5.54e-06	0.000189	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NFKB1—psoriasis	5.49e-06	0.000187	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TYK2—psoriasis	5.39e-06	0.000184	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAT—psoriasis	5.37e-06	0.000183	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—psoriasis	5.35e-06	0.000182	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—psoriasis	5.34e-06	0.000182	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—psoriasis	5.32e-06	0.000181	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TYK2—psoriasis	5.3e-06	0.000181	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—psoriasis	5.3e-06	0.000181	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—psoriasis	5.26e-06	0.000179	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—psoriasis	5.25e-06	0.000179	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—psoriasis	5.17e-06	0.000176	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—JUN—psoriasis	5.15e-06	0.000175	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—psoriasis	5.08e-06	0.000173	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—psoriasis	5.06e-06	0.000172	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—psoriasis	5.05e-06	0.000172	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—psoriasis	5e-06	0.00017	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—psoriasis	4.98e-06	0.00017	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—JUN—psoriasis	4.97e-06	0.000169	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NFKB1—psoriasis	4.95e-06	0.000169	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—JUN—psoriasis	4.94e-06	0.000168	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—psoriasis	4.93e-06	0.000168	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—psoriasis	4.93e-06	0.000168	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—psoriasis	4.92e-06	0.000168	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TYK2—psoriasis	4.82e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—JUN—psoriasis	4.81e-06	0.000164	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NFKB1—psoriasis	4.78e-06	0.000163	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NFKB1—psoriasis	4.76e-06	0.000162	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—psoriasis	4.69e-06	0.00016	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NFKB1—psoriasis	4.63e-06	0.000158	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—psoriasis	4.62e-06	0.000157	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—psoriasis	4.5e-06	0.000153	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—psoriasis	4.46e-06	0.000152	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—psoriasis	4.45e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—psoriasis	4.4e-06	0.00015	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—psoriasis	4.39e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—psoriasis	4.36e-06	0.000149	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—psoriasis	4.34e-06	0.000148	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—psoriasis	4.32e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—psoriasis	4.31e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—psoriasis	4.3e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—psoriasis	4.29e-06	0.000146	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—psoriasis	4.29e-06	0.000146	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—psoriasis	4.28e-06	0.000146	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—psoriasis	4.24e-06	0.000144	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—psoriasis	4.2e-06	0.000143	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—psoriasis	4.2e-06	0.000143	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NFKB1—psoriasis	4.2e-06	0.000143	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—psoriasis	4.17e-06	0.000142	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—psoriasis	4.16e-06	0.000142	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAT—psoriasis	4.14e-06	0.000141	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NFKB1—psoriasis	4.13e-06	0.000141	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—psoriasis	4.04e-06	0.000138	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—psoriasis	4.02e-06	0.000137	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—psoriasis	3.99e-06	0.000136	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—psoriasis	3.94e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—psoriasis	3.9e-06	0.000133	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—psoriasis	3.88e-06	0.000132	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—psoriasis	3.81e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—psoriasis	3.81e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—psoriasis	3.77e-06	0.000129	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—psoriasis	3.76e-06	0.000128	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NFKB1—psoriasis	3.76e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—psoriasis	3.75e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—psoriasis	3.71e-06	0.000127	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—psoriasis	3.7e-06	0.000126	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—psoriasis	3.63e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—psoriasis	3.49e-06	0.000119	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—psoriasis	3.44e-06	0.000117	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—psoriasis	3.41e-06	0.000116	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—psoriasis	3.4e-06	0.000116	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—psoriasis	3.38e-06	0.000115	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—psoriasis	3.28e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—psoriasis	3.26e-06	0.000111	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—psoriasis	3.22e-06	0.00011	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—psoriasis	3.17e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—psoriasis	3.11e-06	0.000106	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—psoriasis	3e-06	0.000102	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—psoriasis	2.99e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—psoriasis	2.9e-06	9.9e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—psoriasis	2.88e-06	9.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—psoriasis	2.83e-06	9.66e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—psoriasis	2.8e-06	9.56e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—psoriasis	2.64e-06	8.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—psoriasis	2.59e-06	8.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—psoriasis	2.58e-06	8.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—psoriasis	2.36e-06	8.04e-05	CbGpPWpGaD
